Fundraising Fox
/People
Sign in

Greg Johnson

Investor

Founder and Managing Director at Prolog Ventures

St Louis, Missouri, United States

Find your path to Greg

238 people in our graph can introduce you to Greg.

Sign up to see every warm intro you have to Greg

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Greg. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

About

A Prolog co-founder and managing director with over 30 years in venture capital, Greg played an early-stage role in funding companies including Genelabs, Novellus, UroCor and Stereotaxis. He previously was a general partner at Gateway Associates and began his investing career in 1985 at Monsanto, where he oversaw its $80M venture portfolio. He holds a doctorate in physics from the University of Rochester and a bachelor's degree from MIT.

Contact· self-published, not guessed

Invests in

Medical DevicesNew Materials

Experience

  1. Prolog VenturesManaging Directorcurrent2000 — present
  2. Veran Medical TechnologiesDirector2008 — 2018
  3. Akermin, Inc.Director2006 — 2016Greater St. Louis Area
  4. PixelEXX Systems, Inc.Director2010 — 2015Greater Chicago Area
  5. KereosDirector2005 — 2015
  6. IntelliCyt CorporationDirector2012 — 2014
  7. SingulexDirector2002 — 2012
  8. EraGen BiosciencesDirector2005 — 2011
  9. Gateway AssociatesGeneral Partner1987 — 2001Greater St. Louis Area
  10. Monsanto Venture CapitalVice President1985 — 1987St. Louis
  11. MonsantoDirector, Business Development1981 — 1985Brussels Area, Belgium

Skills & more

CommercializationTechnology TransferR&DVenture CapitalEnterprise ValuationStart-upsBusiness DevelopmentEntrepreneurshipLife SciencesBusiness StrategyBiotechnologyMergers & Acquisitions
+11 moreCorporate DevelopmentDue DiligenceStrategic PartnershipsProduct DevelopmentCross-functional Team LeadershipPrivate EquityMedical DevicesInvestmentsStrategic PlanningStrategyManagement

From Greg's professional profile.

Investments

Investor

GenelabsNovellusStereotaxisUroCor

Per the firm's website.

Colleagues at Prolog Ventures

Aman Kabeer
Investor at FirstMark Capital
Brian Clevinger
Founder and Managing Director at Prolog Ventures
Ilya Nykin
Founder and Managing Director at Prolog Ventures
Rob Rosenberg
Managing Director at Prolog Ventures
Teddy Shalon
Technology Partner at Prolog Ventures

Frequently asked questions

Who is Greg Johnson?
A Prolog co-founder and managing director with over 30 years in venture capital, Greg played an early-stage role in funding companies including Genelabs, Novellus, UroCor and Stereotaxis. He previously was a general partner at Gateway Associates and began his investing career in 1985 at Monsanto, where he oversaw its $80M venture portfolio. He holds a doctorate in physics from the University of Rochester and a bachelor's degree from MIT.
Where does Greg Johnson work?
Greg Johnson is Founder and Managing Director at Prolog Ventures.
What does Greg Johnson invest in?
Greg Johnson invests in Medical Devices, New Materials.
What companies has Greg Johnson invested in?
Investments tracked here include Genelabs, Novellus, Stereotaxis, UroCor.
Where did Greg Johnson go to school?
Greg Johnson studied at Massachusetts Institute of Technology (S.B., Physics); University of Rochester (Ph.D., Physics).

Same school

Shared employers